about
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, inclu...
Read More
47.54
0.21
(0.44%)
253.5K
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
AnaptysBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..